CAISMOV24, a new human low-grade serous ovarian carcinoma cell line.
Rodrigo Fernandes da SilvaDaniela Maira CardozoGisele Olinto Libanio RodriguesCaroline Natânia de Souza-AraújoNatacha Azussa MigitaLiliana Aparecida Lucci de Angelo AndradeSophie DerchainJosé Andrés YunesFernando GuimarãesPublished in: BMC cancer (2017)
Our results corroborate with the idea that genomic alterations, depicted by CNVs, can be used for subtyping epithelial ovarian carcinomas. Additionally, CAISMOV24 cell line was characterized as a low-grade serous ovarian carcinoma, which still resembles its primary malignant cells.